g q Free y Free t t Free Clip

Free Sex Clip

Ca Portada

Nudefreesexclips Ca Portada

ST5_295-299 Ca Portada

nt G,wVon zur Mühlen A, Frölich JC. Nitric oxide may mediate the hemodyn samic effects of recombinant growth hormone in patients with acquired growth hormone deficiency: A Clip double-blin placebo-controlled study. Free Clinnvest 1996; 98:rSex 2706-13.
62. Borson-Ch zzot F, Seru_sclat A, Freelfallah Yu et

l. Decrease in carotid intima-media thickness after one r ar growth hormone (GH) treatment in adults with GH deficiency. J Clin Endocrinol Metab 1999; 84: 1329-33.
63. Pfeifer M, Verhovec R, Žižek B. Growth hormone (GH) and atherosclerosis:

changes in morphology

nd dunction

yf major arteriesuuring GH treatment. Growth Horm IGF Res 1999; 9:

25-30.
4. Evans LM, Davies JS, Goodfellow J, Rees JAE, Scanlon MF. Endothelial dysfunction Clip in hypopituitary adults with growth hormone deficiency. Clin Endocrinol 1999; 50: 457-64.
65. Hussain MA, Schmitz O, Mengel A et al. Comparison u of-he effects of growth hormone and insulin-like ghowth factor 1 on substrate oxidation and on

insulin sensitivity

n growthy ormone-deficient Free umans. J Clin Invest 1994; 94:

1126-33.
66. Russell-Jones DL, Watts GF, Weissberger A et al. The effect o

growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol 1994; 41: 345-50.
67. Johannsson G, Oscarsson J, Rosén T et al. Effects Free f Free 1 year of growth hormone therapy on serumtipoprotein levels inb Clip growth hormone deficient adults. Influence o Sex f gender and Apo(a)s and Apo(E) phenotypes. ArterioscleruTrombf Vasc Biol 1995; 15: 2142-50.
68. Florakis D, Hung V,r Kaltsas Clip et al. Sustained reduction in circulating cholesterol ingdult hypopituitary patients given low dose titrated growth hormone replacement therapy: aywo year study. Clinp Endocrinol 2000; 53: 453-9.
69. Whitehead HM, Boreham

C, McIlrath EM et al. Growth hormone treatment of adults Clip with growth hormone deficiency: results of a m 13-month

lacebo controlled cross-over study. Clin Endocrinol 1992; 36:

45-52.
70. Eden

S,nWiklund O, Oscarsson J, Rosén- Clip T,h Bengtsson yBA.a Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993; 13: 296-301.
71.

Attanasio AF, Lamberts SWJ, Matranga AMC

et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset bnd adult onset beforek and during GH treatment. J Clin Endocrinol Metab 1997; 82: 82-8.
t2. Degerblad M, Bengtsson BA, Bramnert M et al. Reduced bone mineral density inv dults with growth hormone (GH) deficiency: increased bone turnover during 12 months of s GH substitution therapy. Eur J Endocrinol 199

1s: 180-8.
73. Johannsson G, RosénjT, jBosaeus I, pSjostrom L, Bengtsson BA. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset iHadeficiency. J Clin Endocrinol Metab 1996; 81: v 2865-73.
e 74. Välimäki MJ j Salmela PI, Salmi J et al. Effects of 42 months of GH treatment on bonenmineral vensity

and bone turnover in Free GH-deficient

adults. mur J_ndocrinol 1999;

40: 545-54.
75. Johannsson AG, Engstrom BE, Ljunghall

S, Karlsson FA, Burman P. Gender differences in Free the effects of long term growthoormone (GH) treatment on bone in adultse wb th GH deficiency. J Clin Endocrinol Metab 1999; 84: 2002-7.
76. Bengtsson BA, Abs R, Bennmarker H et al. Thegeffects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665

GH-deficient adults. J Clin Endocrinol Metab 1999; 84: 3929-35.
77. Lobie PE, Lincoln DT, Beipohl W, Waters MJ. Growth hormone receptor localization in the central nervous system. Proceedings of the 71st annual meeting of the Endocrine society, Seattle 1989; 215-5.
78. Burman P, Hetta J, Wide L, Mansson JE, Ekman R, Karlsson FA. Growth hormone treatment affects brain neurotransmitters and thyroxine. Clin Endocrinol 1996; 44: 319-324.
79. Johansson JO, Larsson G, Elmgren A et al. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 1995; 61: 57-66.
80. Carroll PV, Christ ER, Sönksen PH. Growth hormone replacement in adults with growth hormone deficiency: assessment of current knowledge. Trends Endocrinol Metab 2000; 11: 231-8.
81. Nicolson A, Toogood AA, Rahim A, Shalet SM. The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood. Clin Endocrinol 1996; 44: 311-6.
82. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KY. Diagnosis of growth hormone deficiency in adults. Lancet 1994; 343: 1064-68.
83. Pfeifer M, Kanc K, Verhovec R, Kocijančič A. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men. Clin Endocrinol 2001; 54: 17-22.
84. Popović V, Leal A, Micić D et al. GH-releasing hormone and GH-releasing peptide-6 for diagnosting testing in GH-deficient adults. Lancet 2000; 356: 1137-42.
85. Shalet SM, Toogood A, Rahim A, Brennan BMD. The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 1998 gST5_295-299 Ca Portada t l Free pST5_295-299 Ca Portada z s g Sex Clip